HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sylwia Wiśniowska-Śmiałek Selected Research

Angiotensin Receptors (Angiotensin II Receptor)

11/2020Comparison of the 12-month kinetics of the serum markers of fibrosis between treatment with angiotensin receptor-neprilysin inhibitors and angiotensin-converting enzyme inhibitors in patients with heart failure with reduced ejection fraction.
1/2017Angiotensin receptor neprilysin inhibitor treatment is safe and potentially efficacious in end‑stage hypertrophic cardiomyopathy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sylwia Wiśniowska-Śmiałek Research Topics

Disease

15Fibrosis (Cirrhosis)
03/2024 - 03/2017
10Heart Failure
05/2024 - 01/2018
10Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2022 - 03/2017
3Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
01/2023 - 01/2017
2Infections
05/2024 - 01/2020
2COVID-19
09/2023 - 01/2023
2Cardiovascular Diseases (Cardiovascular Disease)
03/2021 - 01/2020
2Endocarditis
01/2020 - 01/2020
1Wounds and Injuries (Trauma)
05/2024
1Malnutrition (Nutritional Deficiencies)
11/2023
1Ventricular Tachycardia
01/2023
1Hypertension (High Blood Pressure)
01/2023
1Aortic Valve Stenosis (Aortic Stenosis)
01/2022
1Bundle-Branch Block (Fascicular Block)
10/2020
1Diabetes Mellitus
10/2020
1Stroke (Strokes)
10/2020
1Neoplasms (Cancer)
06/2017

Drug/Important Bio-Agent (IBA)

9Biomarkers (Surrogate Marker)IBA
01/2023 - 03/2017
5MicroRNAs (MicroRNA)IBA
01/2022 - 03/2017
4GadoliniumIBA
03/2024 - 01/2021
3Brain Natriuretic Peptide (Natrecor)FDA Link
01/2023 - 10/2020
3Transforming Growth Factors (Transforming Growth Factor)IBA
01/2023 - 03/2018
3Galectin 3 (LGALS3)IBA
01/2023 - 01/2020
3CollagenIBA
01/2022 - 06/2017
3Connective Tissue Growth FactorIBA
01/2020 - 06/2017
3procollagen type I carboxy terminal peptide (PICP)IBA
01/2020 - 06/2017
3procollagen Type III-N-terminal peptide (PIIP)IBA
01/2020 - 06/2017
2pro-brain natriuretic peptide (1-76)IBA
01/2023 - 01/2021
2Trinitrotoluene (TNT)IBA
01/2023 - 01/2021
2Troponin T (Troponin T1)IBA
01/2023 - 01/2021
2FibrinIBA
01/2022 - 01/2020
2Neprilysin (Neutral Endopeptidase)IBA
11/2020 - 01/2017
2Angiotensin Receptors (Angiotensin II Receptor)IBA
11/2020 - 01/2017
2Collagen Type I (Type I Collagen)IBA
01/2020 - 03/2018
2OximesIBA
01/2020 - 01/2020
2Peptides (Polypeptides)IBA
03/2018 - 06/2017
2Matrix Metalloproteinases (MMPs)IBA
03/2018 - 06/2017
1Methicillin (Metin)FDA Link
05/2024
1DiureticsIBA
01/2023
1LDL CholesterolIBA
01/2023
1ProcollagenIBA
01/2023
1Lipoprotein(a)IBA
01/2022
1ApolipoproteinsIBA
01/2022
1LipidsIBA
01/2022
1mouse MIRN29 microRNAIBA
01/2022
1sacubitril and valsartan sodium hydrate drug combinationIBA
01/2021
1Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2020
1Eplerenone (Inspra)FDA LinkGeneric
10/2020
1candesartanIBA
10/2020
1Glucose (Dextrose)FDA LinkGeneric
01/2020
1SodiumIBA
01/2020
1SymportersIBA
01/2020
1ThrombinFDA Link
01/2020
1Procollagen Type IIBA
03/2018
1Proteins (Proteins, Gene)FDA Link
03/2018
1OsteopontinIBA
03/2018
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2017

Therapy/Procedure

6Heart-Assist Devices
05/2024 - 01/2018
2Heart Transplantation (Grafting, Heart)
05/2024 - 05/2024
2Therapeutics
05/2024 - 10/2020
1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2020